In oral SCC, Chou et al. [41] revealed the downregulation of SOX2 led to reduced proliferation, self-renewal, and tumorigenicity in oral cancer stem cells (CSCs). The gene discussed is SOX2; the disease is lip and oral cavity carcinoma.